Literature DB >> 21558894

Congenital pyriform aperture stenosis.

Gaurav Bharti1, Leslie Groves, Claire Sanger, Louis C Argenta.   

Abstract

Neonates rely on the nasal airway for their source of air; thus, any compromise in the ability to inhale will dramatically alter their ability to breathe. Congenital nasal pyriform aperture stenosis is a rare yet serious form of airway obstruction due to overgrowth of the maxilla at the medial nasal process. Infants typically present with difficulty feeding and obvious difficulty breathing. Radiologic imaging aids in confirming the diagnosis and assists in operative planning to open the medial nasal process to reduce airway resistance. Further corrective surgery is often needed and is planned commensurate with facial growth. We present a novel case of a child diagnosed with congenital nasal pyriform aperture stenosis who has performed extraordinarily well intellectually and has achieved an excellent cosmetic and physiological reconstruction of the nose and airway.

Entities:  

Mesh:

Year:  2011        PMID: 21558894     DOI: 10.1097/SCS.0b013e31821016b7

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

1.  CT findings of congenital neonatal pyriform aperture stenosis.

Authors:  Halimah Abu Bakar Sidek; Yong Guang Teh; Anithaa Tangaperumal; Faizah Mohd Zaki; Thean Yean Kew
Journal:  Oxf Med Case Reports       Date:  2021-05-24

2.  Newborn nasal obstruction due to congenital nasal pyriform aperture stenosis.

Authors:  Thiago L I Serrano; Leopoldo Pfeilsticker; Vanessa Silva; Igor Hazboun; Jorge Paschoal; Rebecca Maunsell; Eulalia Sakano
Journal:  Allergy Rhinol (Providence)       Date:  2016-01

3.  Balloon dilation and rapid maxillary expansion: a novel combination treatment for congenital nasal pyriform aperture stenosis in an infant.

Authors:  Emanuela Sitzia; Sara Santarsiero; Filippo Maria Tucci; Giovanni De Vincentiis; Angela Galeotti; Paola Festa
Journal:  Ital J Pediatr       Date:  2021-09-16       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.